NCT04952376.

Study name	Equitable access to COVID‐19 vaccines
Starting date	7 July 2021
Contact information	Farhia Omar, Omar.Farhia@mayo.edu Idali Cuellar, Cuellar.Idali@mayo.edu
Methods	Study design: randomised controlled trial Type of publication: trial registration Setting: Adelante Healthcare Country: USA Language: English
Intervention	Personalised text messages SMS (active comparator): vaccine availability and appointment information, Links to information or phone for scheduling will be provided Personalised text message: vaccine availability and appointment information via a personalized message text from the primary care provider interactive or 2‐way SMS: vaccine availability and appointment information via interactive 2‐way SMS options, personalized messaging
Population	Population: patient population Inclusion criteria: 18 and older, receiving Adelante Healthcare Exclusion criteria: NR
Outcomes	Vaccine uptake (Dose 1 COVID‐19 Vaccine (after 30 days),  Dose 2 COVID‐19 Vaccine (after 60 days), Engagement (after 30 days).
Estimated completion date and number of participants	June 2022, 1500 planned
Notes	COI: NR Funding: Mayo Clinic